QurAlis Revenue and Competitors
Estimated Revenue & Valuation
- QurAlis's estimated annual revenue is currently $15.7M per year.
- QurAlis's estimated revenue per employee is $173,944
Employee Data
- QurAlis has 90 Employees.
- QurAlis grew their employee count by 22% last year.
QurAlis's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and CEO QurAlis | Reveal Email/Phone |
2 | Chief Medical Officer | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | VP Global Head Clinical Development Ops | Reveal Email/Phone |
5 | SVP, Tralational Science & Portfolio Strategy | Reveal Email/Phone |
6 | VP External Manufacturing | Reveal Email/Phone |
7 | Head Discovery, Senior Director | Reveal Email/Phone |
8 | Chief Technology Officer | Reveal Email/Phone |
9 | Chief Business Officer | Reveal Email/Phone |
10 | Chief Scientific Officer | Reveal Email/Phone |
QurAlis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 1 | -50% | N/A | N/A |
#3 | $5.1M | 33 | 22% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 2 | -60% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | N/A | 11 | 10% | N/A | N/A |
#10 | $5.4M | 29 | 0% | N/A | N/A |
What Is QurAlis?
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. We are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus our programs on tackling specific disease-causing mechanisms.
keywords:N/A
N/A
Total Funding
90
Number of Employees
$15.7M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
QurAlis News
2022-04-13 - 2022 Henri Termeer Transatlantic Connections Award Honorees Announced by
Termeer Foundation as Part of Program Supporting Emerging Life Science
Leaders in the Netherlands and Massachusetts
Kasper Roet, of QurAlis Corporation and Koenraad Wiedhaup, of Leyden Labs presented with annual award at Innovation for Health conference in...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.4M | 90 | 29% | N/A |
#2 | $10.8M | 90 | -8% | N/A |
#3 | $11.5M | 91 | 20% | N/A |
#4 | $28.4M | 91 | -19% | N/A |
#5 | $21.6M | 91 | 36% | N/A |